{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["5\u03b1-reductase activity", "Benign prostatic hyperplasia", "Evodia rutaecarpa Bentham", "apoptosis", "cell growth"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29690562", "DateCompleted": {"Year": "2018", "Month": "09", "Day": "24"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "04", "Day": "22"}], "Language": ["eng"], "ELocationID": ["523", "10.3390/nu10040523"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "10", "Issue": "4", "PubDate": {"Year": "2018", "Month": "Apr", "Day": "22"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Ethanol Extract of <i>Evodia rutaecarpa</i> Attenuates Cell Growth through Caspase-Dependent Apoptosis in Benign Prostatic Hyperplasia-1 Cells.", "Abstract": {"AbstractText": ["The dried fruits of <i>Evodia rutaecarpa</i> Bentham have been used widely as a herbal medicine for the treatment of inflammatory disorders and abdominal pain. Benign prostatic hyperplasia (BPH) is a nonmalignant disease characterized by overgrowth of prostates. Despite the pharmacological efficacy of the fruits of <i>E. rutaecarpa</i> against various diseases, their effects against BPH have not been reported. Here, we investigated the inhibitory activity of a 70% ethanol extract of <i>E. rutaecarpa</i> (EEER) against BPH, and its underlying mechanisms regarding cell growth of BPH using BPH-1 cells. An in vitro 5&alpha;-reductase activity assay showed that EEER exhibited inhibitory activity against 5&alpha;-reductase. In BPH-1 cells, EEER treatment inhibited cell viability and reduced the expression of the proliferating cell nuclear antigen proliferating cell nuclear antigen (PCNA), cyclin D1, and phosphor-ERK1/2 proteins. Moreover, EEER also induced apoptosis, with chromatin condensation, apoptotic bodies, and internucleosomal DNA fragmentation. Regarding its underlying mechanisms, EEER exacerbated the activation of caspase-8 and caspase-3 in a concentration-dependent manner and eventually caused the cleavage of PARP. Taken together, these data demonstrated that EEER had a potent 5&alpha;-reductase inhibitory activity and that EEER treatment in BPH-1 cells inhibited cell viability via caspase-8- and caspase-3-dependent apoptosis. Therefore, EEER may be a potential phytotherapeutic agent for the treatment of BPH."]}, "AuthorList": [{"Identifier": ["0000-0002-4720-4719"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Korea. eunsook@kiom.re.kr."}], "LastName": "Park", "ForeName": "Eunsook", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Korea. cozy11@kiom.re.kr."}], "LastName": "Lee", "ForeName": "Mee-Young", "Initials": "MY"}, {"Identifier": ["0000-0002-8156-446X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Korea. csseo0914@kiom.re.kr."}], "LastName": "Seo", "ForeName": "Chang-Seob", "Initials": "CS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Korea. jihye1684@kiom.re.kr."}], "LastName": "Jang", "ForeName": "Ji-Hye", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Engineering, College of Biomedical Science, Daegu Haany University, 1 Hanuidae-ro, Gyeongsan-si, Gyeongsangbuk-do 38610, Korea. ykim@dhu.ac.kr."}], "LastName": "Kim", "ForeName": "Yong-Ung", "Initials": "YU"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Korea. hkshin@kiom.re.kr."}], "LastName": "Shin", "ForeName": "Hyeun-Kyoo", "Initials": "HK"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "5-alpha Reductase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "CASP3 protein, human"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "CASP8 protein, human"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 8"}], "CommentsCorrectionsList": [{"RefSource": "J Urol. 2019 Jun;201(6):1030. doi: 10.1097/01.JU.0000554644.86435.6c", "PMID": "30864929"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "5-alpha Reductase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspase 3"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspase 8"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["chemistry"], "DescriptorName": "Evodia"}, {"QualifierName": [], "DescriptorName": "Fruit"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "enzymology", "pathology"], "DescriptorName": "Prostate"}, {"QualifierName": ["drug therapy", "enzymology", "pathology"], "DescriptorName": "Prostatic Hyperplasia"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Time Factors"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Tang W., Eisenbrand G. Chinese Drugs of Plant Origin. Springer; Heidelberg, Germany: 1992. Evodia rutaecarpa (juss.) benth; pp. 509\u2013514."}, {"Citation": "Yu L.L., Liao J.F., Chen C.F. Anti-diarrheal effect of water extract of evodiae fructus in mice. J. Ethnopharmacol. 2000;73:39\u201345. doi: 10.1016/S0378-8741(00)00267-1.", "ArticleIdList": ["10.1016/S0378-8741(00)00267-1", "11025137"]}, {"Citation": "Yu L.L., Liao J.F., Chen C.F. Effect of the crude extract of evodiae fructus on the intestinal transit in mice. Planta Med. 1994;60:308\u2013312. doi: 10.1055/s-2006-959490.", "ArticleIdList": ["10.1055/s-2006-959490", "7938263"]}, {"Citation": "Chiou W.F., Ko H.C., Chen C.F., Chou C.J. Evodia rutaecarpa protects against circulation failure and organ dysfunction in endotoxaemic rats through modulating nitric oxide release. J. Pharm. Pharmacol. 2002;54:1399\u20131405. doi: 10.1211/002235702760345491.", "ArticleIdList": ["10.1211/002235702760345491", "12396303"]}, {"Citation": "Ko H.C., Wang Y.H., Liou K.T., Chen C.M., Chen C.H., Wang W.Y., Chang S., Hou Y.C., Chen K.T., Chen C.F., et al. Anti-inflammatory effects and mechanisms of the ethanol extract of evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. Eur. J. Pharmacol. 2007;555:211\u2013217. doi: 10.1016/j.ejphar.2006.10.002.", "ArticleIdList": ["10.1016/j.ejphar.2006.10.002", "17109845"]}, {"Citation": "Cho M.H., Shim S.M., Lee S.R., Mar W., Kim G.H. Effect of evodiae fructus extracts on gene expressions related with alcohol metabolism and antioxidation in ethanol-loaded mice. Food Chem. Toxicol. 2005;43:1365\u20131371. doi: 10.1016/j.fct.2005.03.010.", "ArticleIdList": ["10.1016/j.fct.2005.03.010", "15913877"]}, {"Citation": "Park S.Y., Park C., Park S.H., Hong S.H., Kim G.Y., Hong S.H., Choi Y.H. Induction of apoptosis by ethanol extract of evodia rutaecarpa in hela human cervical cancer cells via activation of amp-activated protein kinase. BioSci. Trends. 2017;10:467\u2013476. doi: 10.5582/bst.2016.01170.", "ArticleIdList": ["10.5582/bst.2016.01170", "27890875"]}, {"Citation": "Oesterling J.E. Benign prostatic hyperplasia: A review of its histogenesis and natural history. Prostate. 1996;29:67\u201373. doi: 10.1002/(SICI)1097-0045(1996)6+<67::AID-PROS13>3.0.CO;2-P.", "ArticleIdList": ["10.1002/(SICI)1097-0045(1996)6+<67::AID-PROS13>3.0.CO;2-P", "8630233"]}, {"Citation": "McVary K.T., Roehrborn C.G., Avins A.L., Barry M.J., Bruskewitz R.C., Donnell R.F., Foster H.E., Jr., Gonzalez C.M., Kaplan S.A., Penson D.F., et al. Update on aua guideline on the management of benign prostatic hyperplasia. J. Urol. 2011;185:1793\u20131803. doi: 10.1016/j.juro.2011.01.074.", "ArticleIdList": ["10.1016/j.juro.2011.01.074", "21420124"]}, {"Citation": "Horton R., Hsieh P., Barberia J., Pages L., Cosgrove M. Altered blood androgens in elderly men with prostate hyperplasia. J. Clin. Endocrinol. Metab. 1975;41:793\u2013796. doi: 10.1210/jcem-41-4-793.", "ArticleIdList": ["10.1210/jcem-41-4-793", "1176586"]}, {"Citation": "Carson C., 3rd, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 2003;61:2\u20137. doi: 10.1016/S0090-4295(03)00045-1.", "ArticleIdList": ["10.1016/S0090-4295(03)00045-1", "12657354"]}, {"Citation": "Clark R.V., Hermann D.J., Cunningham G.R., Wilson T.H., Morrill B.B., Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J. Clin. Endocrinol. Metab. 2004;89:2179\u20132184. doi: 10.1210/jc.2003-030330.", "ArticleIdList": ["10.1210/jc.2003-030330", "15126539"]}, {"Citation": "Vaughan D., Imperato-McGinley J., McConnell J., Matsumoto A.M., Bracken B., Roy J., Sullivan M., Pappas F., Cook T., Daurio C., et al. Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology. 2002;60:1040\u20131044. doi: 10.1016/S0090-4295(02)01971-4.", "ArticleIdList": ["10.1016/S0090-4295(02)01971-4", "12475666"]}, {"Citation": "Corona G., Tirabassi G., Santi D., Maseroli E., Gacci M., Dicuio M., Sforza A., Mannucci E., Maggi M. Sexual dysfunction in subjects treated with inhibitors of 5alpha-reductase for benign prostatic hyperplasia: A comprehensive review and meta-analysis. Andrology. 2017;5:671\u2013678. doi: 10.1111/andr.12353.", "ArticleIdList": ["10.1111/andr.12353", "28453908"]}, {"Citation": "Nickel J.C., Gilling P., Tammela T.L., Morrill B., Wilson T.H., Rittmaster R.S. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: The enlarged prostate international comparator study (epics) BJU Int. 2011;108:388\u2013394. doi: 10.1111/j.1464-410X.2011.10195.x.", "ArticleIdList": ["10.1111/j.1464-410X.2011.10195.x", "21631695"]}, {"Citation": "Sharma M., Chadha R., Dhingra N. Phytotherapeutic agents for benign prostatic hyperplasia: An overview. Mini Rev. Med. Chem. 2017;17:1346\u20131363. doi: 10.2174/1389557516666160621103817.", "ArticleIdList": ["10.2174/1389557516666160621103817", "27337973"]}, {"Citation": "Kim S., Kim Y.U., Ma E. Synthesis and 5alpha-reductase inhibitory activity of c(2)(1) steroids having 1,4-diene or 4,6-diene 20-ones and 4-azasteroid 20-oximes. Molecules. 2011;17:355\u2013368. doi: 10.3390/molecules17010355.", "ArticleIdList": ["10.3390/molecules17010355", "PMC6268135", "22210173"]}, {"Citation": "Park E., Lee M.Y., Seo C.S., Jeon W.Y., Shin H.K. Yongdamsagan-tang, a traditional herbal formula, inhibits cell growth through the suppression of proliferation and inflammation in benign prostatic hyperplasia epithelial-1 cells. J. Ethnopharmacol. 2017;209:230\u2013235. doi: 10.1016/j.jep.2017.08.002.", "ArticleIdList": ["10.1016/j.jep.2017.08.002", "28782621"]}, {"Citation": "Nicholson D.W., Thornberry N.A. Caspases: Killer proteases. Trends Biochem. Sci. 1997;22:299\u2013306. doi: 10.1016/S0968-0004(97)01085-2.", "ArticleIdList": ["10.1016/S0968-0004(97)01085-2", "9270303"]}, {"Citation": "Wang K., Fan D.D., Jin S., Xing N.Z., Niu Y.N. Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications. Asian J. Androl. 2014;16:274\u2013279.", "ArticleIdList": ["PMC3955340", "24457841"]}, {"Citation": "Roehrborn C.G. Pathology of benign prostatic hyperplasia. Int. J. Impot Res. 2008;20(Suppl. 3):11S\u201318S. doi: 10.1038/ijir.2008.55.", "ArticleIdList": ["10.1038/ijir.2008.55", "19002119"]}, {"Citation": "Stacey D.W. Cyclin d1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr. Opin. Cell Biol. 2003;15:158\u2013163. doi: 10.1016/S0955-0674(03)00008-5.", "ArticleIdList": ["10.1016/S0955-0674(03)00008-5", "12648671"]}, {"Citation": "Wang S.C. Pcna: A silent housekeeper or a potential therapeutic target? Trends Pharmacol. Sci. 2014;35:178\u2013186. doi: 10.1016/j.tips.2014.02.004.", "ArticleIdList": ["10.1016/j.tips.2014.02.004", "24655521"]}, {"Citation": "Zhao Y., Lv M., Lin H., Cui Y., Wei X., Qin Y., Kohama K., Gao Y. Rho-associated protein kinase isoforms stimulate proliferation of vascular smooth muscle cells through erk and induction of cyclin d1 and pcna. Biochem. Biophys. Res. Commun. 2013;432:488\u2013493. doi: 10.1016/j.bbrc.2013.02.009.", "ArticleIdList": ["10.1016/j.bbrc.2013.02.009", "23402758"]}, {"Citation": "Kanduc D., Mittelman A., Serpico R., Sinigaglia E., Sinha A.A., Natale C., Santacroce R., Di Corcia M.G., Lucchese A., Dini L., et al. Cell death: Apoptosis versus necrosis (review) Int. J. Oncol. 2002;21:165\u2013170. doi: 10.3892/ijo.21.1.165.", "ArticleIdList": ["10.3892/ijo.21.1.165", "12063564"]}, {"Citation": "Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456\u20131462. doi: 10.1126/science.7878464.", "ArticleIdList": ["10.1126/science.7878464", "7878464"]}, {"Citation": "Lamkanfi M., Dixit V.M. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe. 2010;8:44\u201354. doi: 10.1016/j.chom.2010.06.007.", "ArticleIdList": ["10.1016/j.chom.2010.06.007", "20638641"]}, {"Citation": "Vanden Berghe T., Grootjans S., Goossens V., Dondelinger Y., Krysko D.V., Takahashi N., Vandenabeele P. Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods. 2013;61:117\u2013129. doi: 10.1016/j.ymeth.2013.02.011.", "ArticleIdList": ["10.1016/j.ymeth.2013.02.011", "23473780"]}, {"Citation": "Saraste A., Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 2000;45:528\u2013537. doi: 10.1016/S0008-6363(99)00384-3.", "ArticleIdList": ["10.1016/S0008-6363(99)00384-3", "10728374"]}, {"Citation": "Li J., Yuan J. Caspases in apoptosis and beyond. Oncogene. 2008;27:6194\u20136206. doi: 10.1038/onc.2008.297.", "ArticleIdList": ["10.1038/onc.2008.297", "18931687"]}, {"Citation": "Green D.R., Llambi F. Cell death signaling. Cold Spring Harb. Perspect. Biol. 2015;7:a006080. doi: 10.1101/cshperspect.a006080.", "ArticleIdList": ["10.1101/cshperspect.a006080", "PMC4665079", "26626938"]}, {"Citation": "Boulares A.H., Yakovlev A.G., Ivanova V., Stoica B.A., Wang G., Iyer S., Smulson M. Role of poly(adp-ribose) polymerase (parp) cleavage in apoptosis. Caspase 3-resistant parp mutant increases rates of apoptosis in transfected cells. J. Biol. Chem. 1999;274:22932\u201322940. doi: 10.1074/jbc.274.33.22932.", "ArticleIdList": ["10.1074/jbc.274.33.22932", "10438458"]}, {"Citation": "Tang X., Huang Z., Chen Y., Liu Y., Liu Y., Zhao J., Yi J. Simultaneous determination of six bioactive compounds in evodiae fructus by high-performance liquid chromatography with diode array detection. J. Chromatogr. Sci. 2014;52:149\u2013156. doi: 10.1093/chromsci/bms261.", "ArticleIdList": ["10.1093/chromsci/bms261", "23377650"]}, {"Citation": "Son J.K., Chang H.W., Jahng Y. Progress in studies on rutaecarpine. Ii.\u2014Synthesis and structure-biological activity relationships. Molecules. 2015;20:10800\u201310821. doi: 10.3390/molecules200610800.", "ArticleIdList": ["10.3390/molecules200610800", "PMC6272352", "26111170"]}, {"Citation": "Yuan X.L., Zhang P., Liu X.M., Du Y.M., Hou X.D., Cheng S., Zhang Z.F. Cytological assessments and transcriptome profiling demonstrate that evodiamine inhibits growth and induces apoptosis in a renal carcinoma cell line. Sci. Rep. 2017;7:12572. doi: 10.1038/s41598-017-12918-y.", "ArticleIdList": ["10.1038/s41598-017-12918-y", "PMC5626725", "28974748"]}, {"Citation": "Jiang J., Hu C. Evodiamine: A novel anti-cancer alkaloid from evodia rutaecarpa. Molecules. 2009;14:1852\u20131859. doi: 10.3390/molecules14051852.", "ArticleIdList": ["10.3390/molecules14051852", "PMC6254303", "19471205"]}, {"Citation": "Fei X.F., Wang B.X., Li T.J., Tashiro S., Minami M., Xing D.J., Ikejima T. Evodiamine, a constituent of evodiae fructus, induces anti-proliferating effects in tumor cells. Cancer Sci. 2003;94:92\u201398. doi: 10.1111/j.1349-7006.2003.tb01358.x.", "ArticleIdList": ["10.1111/j.1349-7006.2003.tb01358.x", "12708481"]}, {"Citation": "Hong J.Y., Park S.H., Min H.Y., Park H.J., Lee S.K. Anti-proliferative effects of evodiamine in human lung cancer cells. J. Cancer Prev. 2014;19:7\u201313. doi: 10.15430/JCP.2014.19.1.7.", "ArticleIdList": ["10.15430/JCP.2014.19.1.7", "PMC4189475", "25337567"]}, {"Citation": "Kan S.F., Yu C.H., Pu H.F., Hsu J.M., Chen M.J., Wang P.S. Anti-proliferative effects of evodiamine on human prostate cancer cell lines du145 and pc3. J. Cell. Biochem. 2007;101:44\u201356. doi: 10.1002/jcb.21036.", "ArticleIdList": ["10.1002/jcb.21036", "17340628"]}, {"Citation": "Kan S.F., Huang W.J., Lin L.C., Wang P.S. Inhibitory effects of evodiamine on the growth of human prostate cancer cell line lncap. Int. J. Cancer. 2004;110:641\u2013651. doi: 10.1002/ijc.20138.", "ArticleIdList": ["10.1002/ijc.20138", "15146552"]}, {"Citation": "Wei L., Jin X., Cao Z., Li W. Evodiamine induces extrinsic and intrinsic apoptosis of ovarian cancer cells via the mitogen-activated protein kinase/phosphatidylinositol-3-kinase/protein kinase b signaling pathways. J. Tradit. Chin. Med. 2016;36:353\u2013359.", "ArticleIdList": ["27468551"]}, {"Citation": "Zhang C., Fan X., Xu X., Yang X., Wang X., Liang H.P. Evodiamine induces caspase-dependent apoptosis and s phase arrest in human colon lovo cells. Anticancer Drugs. 2010;21:766\u2013776. doi: 10.1097/CAD.0b013e32833d26a9.", "ArticleIdList": ["10.1097/CAD.0b013e32833d26a9", "20647931"]}, {"Citation": "Chen M.C., Yu C.H., Wang S.W., Pu H.F., Kan S.F., Lin L.C., Chi C.W., Ho L.L., Lee C.H., Wang P.S. Anti-proliferative effects of evodiamine on human thyroid cancer cell line aro. J. Cell. Biochem. 2010;110:1495\u20131503. doi: 10.1002/jcb.22716.", "ArticleIdList": ["10.1002/jcb.22716", "20503248"]}]}], "History": [{"Year": "2018", "Month": "3", "Day": "9"}, {"Year": "2018", "Month": "4", "Day": "3"}, {"Year": "2018", "Month": "4", "Day": "18"}, {"Year": "2018", "Month": "4", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29690562", "PMC5946308", "10.3390/nu10040523", "nu10040523"]}}]}